Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Long-ping Wen

Long-ping Wen

University of Science & Technology China

Elena Alexandrova

Elena Alexandrova

National Cancer Center Bulgaria

Mian Wu

Mian Wu

University of Science and Technology China

Katarina Jeremic

Katarina Jeremic

University of Belgrade Serbia

Ali Aldameh

Ali Aldameh

Al Zahra cancer centre UAE

Eman Oweida

Eman Oweida

Nmc Royal Hospital UAE

Diana Anderson

Diana Anderson

University of Bradford UK

Jiri Vachtenheim

Jiri Vachtenheim

Charles University Czech Republic

Surgical Oncology 2019

About conference

Surgical Oncology 2019

Oncology is a multidisciplinary super-speciality of which surgical oncology forms an integral component, especially with solid tumors. Surgical oncologists around the world are involved in research extending from detecting the mechanisms underlying the causation of cancer, to its treatment and prevention. The role of a surgical oncologist extends across the whole continuum of care. With continued developments in diagnosis and treatment, the role of a surgical oncologist is ever-changing.

Surgical oncology is a field of Medicine that presented a rapid evolution over the past decades. The increasing incidence of malignancies throughout the globe and their detrimental effects led to an increasing interest in discovering new curative techniques, that could affect and prolong the patients’ life. Surgery has been the cornerstone and its course underwent dramatic changes over the years. Since the beginning of the twentieth century, the aim of the surgeons was to offer the maximal tolerable treatment, as their efforts were focused on delivering as extensive surgical treatments as the patients could tolerate, in order to achieve an acceptable disease control.

Who are Oncologists & Surgical Oncologists?

An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer.

The field of oncology has three major areas: medical, surgical, and radiation.

  • A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy or immunotherapy.
  • surgical oncologist removes the tumor and nearby tissue during surgery. He or she also performs certain types of biopsies to help diagnose cancer.
  • A radiation oncologist treats cancer using radiation therapy.

Other types of oncologists include gynaecologic oncologist, paediatric oncologist, and haematologist-oncologist.

Surgical Oncology 2019 on a whole focusses on the Theme: Let’s work together to live in a cancer free world.

Who are attending Surgical Oncology 2019?

  • The expected attendees  are specialised Oncologists in various fields like Haematologists, Gynaecologists, Dermatologists, Paediatricians specialized in oncology, Oncological surgery, Cancer Researchers, Oncology Professors, Scientists, Radiology and Oncology Researchers, Medical Oncology Faculty, Medical College students, Doctors, Radiology and Oncology Students Nurses and professors from Nursing schools.
  • Anticipating students are welcomed from various fields such as Oncology, Nursing, Medicine, Pharmacy, and Clinical Research Centres.
  • Researchers and scholars from cancer research centres, Individuals from Cancer research universities globally will prefer attending Surgical Oncology 2019 Conference to present their research.
  • Business Entrepreneurs, Medical Devices Manufacturing Companies, Oncological Surgery equipment Manufacturers.

Benefits of attending Global Pediatrics 2019:

  • Surgical Oncology 2019 is an international platform for presenting research about diagnosis, Cure and Prevention of Tumors, exchanging ideas about it and thus, contributes to the dissemination of knowledge in Oncology for the benefit of both the academia and business.
  • This event brings together Oncological surgeons, Haematologists, Gynaecologists, Dermatologists, child specialists and all the eminent researchers and experts in the field of Oncology to explore the advancements in the prevention and management of Cancer diseases.
  • We bring together industry executives, Oncology Pharmacy and Healthcare sectors making the conference a perfect platform to network, share views and knowledge through interactive discussions.
  • Learn the experiences of other researchers who have tackled rare cases and developed the treatment strategies.

Sessions

Cancer Epidemiology

Cancer Epidemiology represents the study of factors responsible for the initiation, metastasis and prognosis of various types of cancer. Epidemiological research findings on cancer can facilitate the formulation of suitable therapeutic treatment methods and preventive medicines for cancer. When cancer is diagnosedstaging tests help determine how extensive the cancer is in terms of its location, size, growth into nearby structures, and spread to other parts of the body.

Three types of epidemiologic research apply to the field of cancer. Descriptive epidemiology focuses on the trends and frequency of disease in a given population. Analytic epidemiology deals with identifying causes and the predisposing risk associated with the development of disease. Clinical epidemiology outlines screening programs and evaluates the impact of prevention strategies on overall outcome. Environmental carcinogens are ubiquitous but often avoidable if aware.

  • Diagnosis & Staging
  • Tests & Procedures
  • Cancer Prevention & Control
  • Cancer Epigenetics
  • Tumor suppressor genes
  • Environmental Carcinogens
  • Gene-Environment Interactions

Cancer: Lifestyle and Nutrition

A cancer diagnosis is often linked to family medical history, lifestyle choices, or something in the environment. And while you can’t control your family history or your whole environment, healthy lifestyle habits such as a good diet, regular physical activity, weight control, and quitting smoking if you’re prone to lighting up are all within your control.

“Risk factors are individualized, but it’s important to know that there are things you can do to lower your risk”. Sometimes it comes down to the simple things, like reapplying sunscreen to prevent skin cancer if you’ve been outside for a while. Knowing what you're up against can help you devise a plan for what screenings you may need to get (and when), what dietary changes could benefit you, and more — all personalized for you. “Modifying one thing might be helpful for one person but not necessarily helpful for someone else”.

Women Oncology

Some of the cancers that most often affect women are breast, colon, endometrial, lung, and cervical, skin, and ovarian cancers. Knowing about these cancers and what you can do to help prevent them or find them early (when they are small and easier to treat) may help save life. Most women with breast cancer will have surgery. The type of surgery you have depends mainly on the size and location of the tumour, the size of the breast.

  • Breast Oncology
  • Breast Implants
  • Surgery For breast cancer
  • Gynaecologic  Cancers

Cancer Therapy

Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain. Therapies employing stem cells are showing increasing promise in the treatment of cancer. Precision medicine is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease. This may also be called personalized medicine.

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy to Treat Cancer
  • Targeted Therapy
  • Hormone Therapy
  • Stem cell therapy
  • Precision Medicine

Types of Surgery for Cancer Treatment

Several types of surgery are helpful to people with cancer. Some surgeries are used in combination with other types of treatmentCurative surgical operations are conducted to remove or destroy cancerous tissue. In a preventive surgery, the surgeon removes tissue that does not yet contain cancer cells, but has the probability of becoming cancerous in the future. The major role of surgery in the diagnosis of cancer lies in the acquisition of tissue for exact histologic diagnosis. Debulking is the reduction of as much of the bulk (volume) of a tumour as possible. It is usually achieved by surgical removal. Surgery to relieve distressing symptoms in an individual with no hope of cure or intent to lengthen their lifespan is considered palliative. Supportive surgery helps make other cancer treatments work effectively. Restorative or reconstructive surgery restores the body’s appearance, or the function of an organ or body part, after major surgery, such as a breast reconstruction after a mastectomy.

  • Curative surgery
  • Preventive surgery
  • Diagnostic surgery
  • Debulking surgery
  • Palliative surgery
  • Supportive surgery
  • Restorative surgery
  • Microscopically controlled surgery
  • Risks and Potential Side Effects of Surgery for Cancer Treatment
  • Lower the Chance of recurrence
  • Cancer incidence and the morality

Surgical Techniques

Conventional surgery makes large incisions (or cuts) through the skin, muscle, and other layers of the body. When most people think of surgery, they picture a doctor using a scalpel and other surgical instruments to cut into and remove, repair, or replace parts of the body affected by disease. Newer surgical techniques are less invasive, use different types of surgical instruments, and lead to less pain and shorter recovery times. Cryosurgery (cryotherapy) is the use of extreme cold in surgery to destroy abnormal or diseased tissue. Laser light is precisely aimed to cut or destroy a tumor. Electro surgery is used in oncology to destroy cancerous or abnormal cells using a high-frequency current. Radiofrequency ablation (RFA) uses heat made by radio waves to kill cancer cells. Mohs surgery is a precise surgical technique used to treat skin cancer. Thoracoscopic surgery (VATS) is a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via small incisions. Laparoscopic surgery & Robotic surgeries are commonly called “minimally invasive” surgery because it involves smaller incisions.

  • Cryosurgery
  • Laser surgery
  • Electro surgery
  • Radiofrequency ablation
  • Mohs surgery
  • Laparoscopic surgery
  • Thoracoscopic surgery
  • Robotic Surgery- Superior Results and Reduced Risks

Neurological Cancer

The brain, spinal cord, and peripheral nervous system can be impacted both by the spread of cancer from other parts of the body and by treatments for cancer occurring elsewhere in the body. Brain tumors are formed by abnormal growths and can appear in different areas of the brain. Benign (not cancerous) tumors may grow and press on nearby areas of the brain, but rarely spread into other tissues. Malignant (cancerous) tumors are likely to grow quickly and spread into other brain tissue. A tumor that grows into or presses on an area of the brain may stop that part of the brain from working the way  it should, whether the tumor itself is benign or malignant, and will then require treatment. The most common type of brain tumor seen does not originate from the brain tissue itself, but rather are metastases from extra cranial cancers such as lung cancer and breast cancer.

Oropharyngeal Cancer

Oropharyngeal cancer is a type of head and neck cancer. Sometimes more than one cancer can occur in the oropharynx and in other parts of the oral cavity, nose, pharynx, larynx(voice box), trachea, or oesophagus at the same time.

Most oropharyngeal cancers are squamous cell carcinomas. Squamous cells are the thin, flat cells that line the inside of the oropharynx.

  • Risk Factors
  • Diagnosis & Evaluation
  • Staging

Thyroid Cancer

Thyroid cancer develops when cells change or mutate. The abnormal cells begin multiplying in thyroid and, once there are enough of them, they form a tumor. Thyroid cancer is more common in women than men. Women tend to get thyroid cancer in their 40s and 50s, while men who get it are usually in their 60s or 70s. About 80% of allthyroid cancers cases are papillary thyroid cancer. Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid. Medullary thyroid cancer starts as a growth of abnormal cancer cells within the thyroid. These special cells are the parafollicular C cells. Anaplastic thyroid cancer, also called undifferentiated thyroid cancer, is very rare and makes up only 1 to 2% of all thyroid cancers.

  • Papillary thyroid cancer
  • Follicular thyroid cancer
  • Medullary Thyroid cancer
  • Anaplastic thyroid cancer

Parathyroid Cancer

Parathyroid cancer is a rare cancer that usually affects people in their forties or fifties and occurs in one of the four parathyroid glands. The parathyroid glands are located in the neck and secrete parathyroid hormone, which enhances the release of calcium into the blood.

In about 90 percent of cases, the early signs of parathyroid cancer are high levels of parathyroid hormone (hyperparathyroidism) and calcium (hypercalcemia) in the blood. In these cases, the cancer is described as hormonally functional because the parathyroid glands are producing excess hormone.

Dermatological Cancer

Skin cancer is an abnormal growth of skin cells. It most often develops on areas of the skin exposed to the sun’s rays. Skin cancer affects people of all colors and races, although those with light skin who sunburn easily have a higher risk. The incidence is highest among outdoor workers, sportsmen, and sunbathers and is inversely related to the amount of melanin skin pigmentation; fair-skinned people are most susceptible. Skin cancers may also develop years after therapeutic x-rays or exposure to carcinogens (eg, arsenic ingestion).

  • Diagnosis
  • Types of Skin Cancer
  • Prevention

Blood Cancer and Bone Cancer

Blood cancers (like leukemia, lymphoma, myeloma, myelodysplastic syndrome and myeloproliferative disorders) affect the production of blood cells and their many functions, such as fighting off infections or preventing serious bleeding. Most of these cancers start in the bone marrow where blood is produced.

  • Types of blood cancers
  • Treatment
  • Recent advances in blood cancer Research

Lung Cancer

Lung cancer is when abnormal cells divide in an uncontrolled way to form a tumour in the lung. The main symptoms are a cough, breathlessness and weight loss. The treatment you need depends on what type you have as well as your general health. Treatments include surgery, chemotherapy and radiotherapy.

  • Symptoms
  • Getting diagnosed
  • Stages, types and grades
  • Risks and causes
  • Survival
  • Treatment

Renal Cancer and Hepatocellular Cancer

Metastatic tumor of kidney is rare. Secondary malignant tumors of the kidney are uncommon, especially originating from hepatocellular carcinoma. As the applications of ultrasound and computed tomography (CT) are increasing, incidental finding of a metastatic tumour of kidney become usual. Renal metastases of patients with history of cancer may mimic primary renal tumors. When the kidney is the only known pathological site of patients with local controlled disease, the differentiation between renal metastases and primary renal cell carcinoma (RCC) may be little.

  • Diagnosis
  • Treatment
  • Research advancements

Pancreatic Cancer and Colorectal Cancer

The pancreas is a gland of the digestive system. The causes of pancreatic cancer are unknown, but smokers are at greater risk. Likewise, the causes of colorectal cancer (including bowel cancer) are unknown but smoking and increasing age are risk factors. Pancreatic cancer is the fifth leading cause of cancer death in Australia, with a five year survival rate of around 5%. The treatment and survival of patients with pancreatic cancer has not changed for over thirty years because there has been little research into the molecular and cell biology associated with it. A barium enema is an X-ray exam that can detect changes or abnormalities in the large intestine (colon). A sigmoidoscopy is a way to view the lower 20 inches of a person's sigmoid colon and rectum. It is one way to screen for colorectal cancer. Colonoscopy is a procedure that enables an examiner (usually a gastroenterologist) to evaluate the inside of the colon (large intestine or large bowel).

  • Rectal Pain
  • Sigmoidoscopy
  • Barium Enema
  • Colon Cancer and Genetic Testing
  • Colonoscopy
  • Rectal cancer
  • Bowel cancer in pregnancy
  • Surgery

Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States. Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

  • Surgery

Cervical Cancer

Cervical cancer occurs when the cells of the cervix grow abnormally and invade other tissues and organs of the body. When it is invasive, this cancer affects the deeper tissues of the cervix and may have spread to other parts of the body (metastasis), most notably the lungs, liver, bladder, vagina, and rectum. However, cervical cancer is slow-growing, so its progression through precancerous changes provides opportunities for prevention, early detection, and treatment.

Esophageal Cancer

Esophageal cancer is cancer that occurs in the esophagus — a long, hollow tube that runs from your throat to your stomach. Esophagus helps move the food we swallow from the back of throat to stomach to be digested.

Esophageal cancer is the sixth most common cause of cancer deaths worldwide. Incidence rates vary within different geographic locations. In some regions, higher rates of esophageal cancer cases may be attributed to tobacco and alcohol use or particular nutritional habits and obesity. Esophageal cancer usually begins in the cells that line the inside of the esophagus. Esophageal cancer can occur anywhere along the esophagus. More men than women get esophageal cancer.

  • Deduction of esophageal cancer
  • Esophageal Cancer treatment
  • Esophageal Cancer surgery

Thymoma & Thymic Cancer

Thymoma and thymic carcinoma are two types of thymus cancer. The thymus is a small organ in the upper chest. It’s in front of and above the heart. It makes white blood cells that help your body fight infection. With these types of cancer, tumors form on the outside of the thymus. Both kinds are rare.

  • Risk Factors and Signs
  • Treatment & Surgery

Reproductive Cancers

Reproductive cancers are cancers that occur in the reproductive organs. They can affect both men and women. In women, these are cancers in the breast, cervix, uterus, vulva, endometrium or ovaries. In men, reproductive cancers can be found in the prostate, testicles and penis.

  • Penile Cancer
  • Testicular Cancer
  • Prostate Cancer

Cranial base center Cancers

Treating tumors at the base of the skull (cranial base) or between the brain and the face and neck (cranio-cervical junction) can be extremely complex. The surrounding areas include a concentration of vital nerves, the spinal cord and major arteries. Symptoms can affect vision, hearing, sense of smell, speech, swallowing, movement and mental faculties.

  • Minimally Invasive Surgery

Paediatric Cancers

The types of cancers that occur most often in children are different from those seen in adults. Leukaemia is a cancer of the blood cells. Chronic leukaemias are rare in childhood. Childhood brain tumors are abnormal growths inside the skull of children. Even benign tumors can be serious. Neuroblastoma is the most common extracranial solid tumor of infancy. Wilms tumor (also called nephroblastoma) is a cancerous tumor in the cells of the kidney. Secondary non-Hodgkin lymphoma is less common among pediatric patients. Rhabdomyosarcoma is cancer of soft tissue (such as muscle), connective tissue (such as tendon or cartilage), or bone. Retinoblastoma is an eye cancer that begins in the retina — the sensitive lining on the inside of your eye. Osteosarcoma and Ewing's sarcoma are the most common malignancies of bone tissues in children. Being pregnant may delay a cancer diagnosis. This is because some cancer symptoms, such as bloating, headaches, breast changes, or rectal bleeding, are also common during pregnancy.

  • Leukemia
  • Brain and spinal cord tumors
  • Neuroblastoma
  • Wilms tumor
  • Lymphoma (including both Hodgkin and non-Hodgkin)
  • Rhabdomyosarcoma
  • Retinoblastoma
  • Bone cancer (including osteosarcoma and Ewing sarcoma)
  • Cancer during pregnancy

Research in surgical oncology

The landscape of cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumour growth has ended. A complex scenario where the molecular features of tumours seem to be the cornerstone of any therapy is now emerging.

Recovery or Coping of Cancer Patients

Each person's experience with cancer is different, and the feelings, emotions, and fears that you have are unique. The values you grew up with may affect how you think about and deal with cancer. Some people may feel they have to be strong and protect their friends and families. Others seek support from loved ones or other cancer survivors or turn to their faith to help them cope. Some seek help from counsellors and others outside the family, while others don't feel comfortable with this approach.

The best health care doesn't come from machinery or buildings. It comes from people.

Market Analysis

Global Image Guided Surgery Devices Market

The cancer therapy market was valued at USD 125730.7 million in 2017, is expected to register a CAGR of about 8.37% during the forecast period, 2018-2023. Cancer is one of the leading causes of morbidity and mortality, globally. Cancer therapies are drugs that block the growth and proliferation of cancer by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells.

The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing for business players. Several market players are already on the lookout for better business strategies to garner a global footprint. Moreover, the players are expected to focus on get into strategic alliances in order to attract a decent consumer base across the world. The major players identified by Transparency Market Research (TMR) include Koninklijke Philips N.V., Siemens Healthineers, Analogic Corporation, GE Healthcare, Stryker, Varian Medical Systems, Inc., Brainlab AG, Medtronic,KARL STORZ GmbH & Co. KG, and Olympus Corporation. The market strategies employed by these prominent players is anticipated to be a decisive standpoint for market progress.

 

Past report

Oncologists  2016: Past Conference Report

The success of the Oncologists  2016 conference has given us the prospect to bring the gathering one more time. Conference Series llc LTD hosted the 10th Global Annual Oncologists Meeting during July 11-13, 2016 at Park Inn by Radisson Köln City West, Cologne, Germany

The conference was focused on learning about Oncologists with the theme “To Say There is Life after Cancer.The conference mainly directs towards addressing main issues like Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2016 is one of the most appreciated Cancer Conferences organized by Conference Series llc LTD. This Oncologists Meeting was discussed on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer,  blood cancer, cervical cancer, colon-rectum cancer, prostate cancer, thyroid cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

 

  • Dr. Diana Anderson, University of Bradford, UK
  • Dr. Karl Reinhard Aigner, Medias Klinikum GmbH & Co KG, Germany
  • Dr. Hirendranath Banerjee, Elizabeth City State University, USA
  • Dr. Ajay Singh, Mitchell Cancer Institute, USA
  • Dr. Matin Burrow, DMB-Diagnostics GmbH, Germany
  • Dr. Martin Kristensson, Visiopharm, Denmark
  • Dr.Michael Retsky, Harvard TH Chan School of Public Health, USA

 

Conference Series llc LTD offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference Series llc LTD and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Oncologists 2016, Conference Series llc LTD would like to announce the commencement of the “16th Global Annual Oncologists Meeting” to be held during April 24-25, 2017 Dubai, UAE. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology and cancer Research.

 For More details: http://annualmeeting.conferenceseries.com/oncologists/

 Let us meet again @ oncologists 2017

Past Conference Report

Oncologists 2017

Oncologists  2017: Past Conference Report

The success of the Oncologists  2017 conference has given us the prospect to bring the gathering one more time. Conferenceseries hosted the 16th Global Annual Oncologists Meeting during April 24-25, 2017 at JW Marriott Dubai, UAE.

The conference was focused on learning about Oncologists with the theme “A step towards Cancer free World.The conference mainly directs towards addressing main issues like Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2017 is one of the most appreciated Cancer Conferences organized by Conferenceseries. This Oncologists Meeting was discussed on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer,  blood cancer, cervical cancer, colon-rectum cancer, prostate cancer, thyroid cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

 

  • Dr. Diana Anderson, University of Bradford, UK
  • Dr. Alok De, Kansas City VA Medical Center, USA
  • Dr. Sadir Alrawi, Alzahra Cancer Center, UAE
  • Dr. Ali Aldameh, Al Zahra cancer centre, UAE
  • Dr. Humaid O Al-Shamsi, The University of Texas, USA
  • Dr. Tarek Dufan, American Hospital Dubai, UAE
  • Dr.Jiri Vachtenheim, Charles University, Czech Republic
  • Dr. Mohammed Y Almaghrabi, Prince Faisal Cancer Center, Saudi Arabia 

Conferencesereies offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferencesereies and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Oncologists 2017, Conferencesereies would like to announce the commencement of the “22nd Global Annual Oncologists Meeting” to be held during May 24-25, 2018 Osaka, Japan. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology and cancer Research.

 For More details: http://annualmeeting.conferenceseries.com/oncologists/

 Let us meet again @ oncologists 2018


Past Reports  Gallery  

Oncologists 2018

Oncologists 2018: Past Conference Report

The success of the Oncologists 2018 conference has given us the prospect to bring the gathering one more time. Conferenceseries llc LTD hosted the 22nd Global Annual Oncologists Meeting during May 24-25, 2018 at Hyatt Regency Osaka, Japan.

The conference was focused on learning about Oncologists with the theme “Welcoming the era of multiplying smiles not Cancer cells. The conference mainly directs towards addressing main issues like Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Oncologists 2018 is one of the most appreciated Cancer Conferences organized by Conferenceseries llc LTD. This Oncologists Meeting was discussed on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer,  blood cancer, cervical cancer, colon-rectum cancer, prostate cancer, thyroid cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Dr. Jacob Gopas, Soroka University Medical Center, Israel
  • Dr. Celestial T. Yap, National University of Singapore, Singapore
  • Dr. kazuko Tatsumura, Gaia Holistic Health, USA
  • Dr. Hydelene B. Dominguez, SLU-Hospital of the Sacred Heart, Philippines
  • Dr. Shuo Deng, National University of Singapore, Singapore
  • Dr. Mei-Ren Pan, Kaohsiung Medical University, Taiwan
  • Dr. Yun Seong Kim, Pusan National University School of Medicine, South Korea
  • Dr. Chi-Wen Luo, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
  • Dr. Yu-Chieh Lee, Taipei Medical University Hospital, Taiwan

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Oncologists 2018, ConferenceSeries llc LTD would like to announce the commencement of the “24th Annual Meet On Surgical Oncology 2019” to be held during March 04-05, 2019 Paris, France. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Surgical Oncology and cancer Research.

 For More details: https://surgicaloncology.conferenceseries.com/

 Let us meet again @ Surgical Oncology 2019


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 4-5, 2019

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Journal of Cancer Diagnosis Journal of Integrative Oncology Journal of Carcinogenesis & Mutagenesis

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


 OR